| To Evaluate the Safety and the Pharmacokinetics of NVP-2203 (NCT05725252) | NVP Healthcare | 2023-05-28 |
| A Study of TAK-227 in Healthy Adults (NCT05818956) | Takeda | 2023-05-25 |
| Modeling Organ Motion During Abdominal Imaging in Healthy Volunteers (NCT05674851) | Duke University | 2023-05-23 |
| A Study to Investigate the Absorption, Metabolism and Excretion of [14C]-BGB-11417 (NCT05844111) | BeiGene | 2023-05-22 |
| A Study to Compare the Relative Bioavailability of Two Iberdomide (CC-220) Formulations and to Assess The Effect Of Food on the Drug Levels of Iberdomide in Healthy Adult Participants (NCT05899738) | Bristol-Myers Squibb | 2023-05-18 |
| Promoting Immune Health by Intermittent Fasting: a Pilot Study (NCT05898360) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2023-05-15 |
| A Study to Learn How the Study Treatment BAY2395840 Moves Into, Through and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Moderate Reduced Kidney Function and in Healthy Male and Female Participants With Normal Kidney Function (NCT05406219) | Bayer | 2023-05-15 |
| A Study to Assess Pharmacokinetics (PK) of Brensocatib Alone and With Multiple Doses of Rifampin or Esomeprozole in Healthy Participants (NCT05826574) | Insmed Incorporated | 2023-05-10 |
| Investigating the Impact of Environmental Factors on the Transcriptomics Profile in Healthy Individuals (NCT06040008) | CENTOGENE GmbH Rostock | 2023-05-09 |
| A Study to Assess Two Forms of The Study Medicine (Ritlecitinib) in Healthy Adult Participants (NCT05852340) | Pfizer | 2023-05-09 |
| A Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]BMS-986419 in Healthy Male Participants (NCT05847439) | Bristol-Myers Squibb | 2023-05-05 |
| A Study to Compare Two Bioanalytical Assays for Tebipenem (NCT05856747) | Spero Therapeutics | 2023-05-04 |
| A Study to Compare How Much of the Study Treatment Finerenone Gets Into the Blood When the Same Amount is Taken in One and in Two Tablets of Different Strengths in Healthy Male Participants (NCT07116512) | Bayer | 2023-05-02 |
| A Study of the Absorption, Metabolism and Excretion of [14C]XZP-3621 in Human (NCT05836805) | Xuanzhu Biopharmaceutical Co., Ltd. | 2023-05-01 |
| A PET Study to Determine Biodistribution and Binding Characteristics of [11C]AZ14132516 in Healthy Participants (NCT05818514) | AstraZeneca | 2023-04-27 |
| Understanding the Effects of Transauricular Vagus Nerve Stimulation on Neural Networks and Autonomic Nervous System (NCT05801809) | Spaulding Rehabilitation Hospital | 2023-04-26 |
| GP681 in Volunteers With Hepatic Impairment Compared With Healthy Volunteers (NCT05814926) | Jiangxi Qingfeng Pharmaceutical Co. Ltd. | 2023-04-26 |
| Safety and Tolerability of DMT in Healthy Adults (NCT05901012) | Universidade Federal do Rio Grande do Norte | 2023-04-26 |
| A First in Human Study of AX-202 in Healthy Subjects and Patients With Psoriasis. (NCT05965089) | Arxx Therapeutics | 2023-04-25 |
| A Study of Multiple Ascending Doses of GSBR-1290 in Japanese and Non-Japanese Healthy Participants (NCT05893043) | Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics | 2023-04-24 |
| Single Ascending Dose Study of NRS 033 in Healthy Volunteers (NCT05724797) | Nirsum Labs | 2023-04-17 |
| Effect of Concurrent and Aerobic Exercise on VO2max, Strength, and Body Composition in Overweight and Obese Adults (NCT05867498) | Universidad de Antioquia | 2023-04-17 |
| FiH Study to Assess Safety and PK of SAD and MAD of ANT3310 Alone and in Combination With Meropenem in Healthy Subjects (NCT05905913) | Antabio | 2023-04-12 |
| Comparative Evaluation of Glass Ionomer and Resin-Based Fissure Sealants on Newly Erupted Permanent First Molars: A 24-Month Randomized Clinical Trial (NCT07115290) | Gulcin Bulut | 2023-04-10 |
| A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986325 in Healthy Japanese Participants (NCT05813717) | Bristol-Myers Squibb | 2023-04-10 |
| A Study to Evaluate the Drug-drug Interaction and Safety of RLD2301 and RLD2007 in Healthy Volunteers (NCT05862090) | Hanmi Pharmaceutical Company Limited | 2023-04-05 |
| A Research Study Looking at How a Single Dose of the Medicine Cagrilintide Works in Participants With Reduced Liver Function and in Healthy Participants With Normal Liver Function and How Cagrilintide is Absorbed and Used by the Body (NCT05564104) | Novo Nordisk A/S | 2023-04-05 |
| A Study to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body, How it Moves Into, Through and Out of the Body When Single and Multiple Amounts Are Taken as Tablets in Japanese Healthy Male Participants (NCT05800444) | Bayer | 2023-04-03 |
| Feldenkrais Method and Stress-Related Responses in Adult Women (NCT07175974) | University of Palermo | 2023-04-01 |
| A Study to Evaluate the Safety, Tolerability, and Drug Levels of Danicamtiv in Healthy Japanese and Caucasian Participants (NCT05806359) | Bristol-Myers Squibb | 2023-03-31 |
| A Study to Evaluate the Drug Levels, Safety, and Tolerability of BMS-986278 in Healthy Chinese Participants (NCT05805904) | Bristol-Myers Squibb | 2023-03-29 |
| Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa (NCT05794230) | Sanofi Pasteur, a Sanofi Company | 2023-03-27 |
| A Trial to Investigate Teprotumumab (High-concentration Formulation) Subcutaneous Administration in Healthy Adult Non-Japanese and Japanese Participants (NCT06674941) | Amgen | 2023-03-24 |
| QG101-23-0 Capsules SAD and MAD Study in Healthy Subjects (NCT05650528) | Amckaus PTY LTD. | 2023-03-21 |
| A Single Ascending Doses Phase I Study to Evaluate the Safety and Pharmacokinetics of RBD4059 in Healthy Subjects (NCT05653037) | Suzhou Ribo Life Science Co. Ltd. | 2023-03-21 |
| Preparation and Feasibility of Exams for Expected Studies (NCT05698810) | University Hospital, Grenoble | 2023-03-20 |
| Tolerance and Safety of an Oral Nutritional Supplement (Adolescent Cohort) (NCT05923593) | Société des Produits Nestlé (SPN) | 2023-03-20 |
| Drug Drug Interaction (DDI) Between Supaglutide and Digoxin or Metformin (NCT05694221) | Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | 2023-03-20 |
| Adolescent Vaping Characterization and Parent Views on Adolescent Vaping Protocol (NCT05669716) | National Institute on Drug Abuse (NIDA) | 2023-03-09 |
| Bioequivalence of a Zanubrutinib Tablet Compared to Capsules in Healthy Adult Participants (NCT05767398) | BeiGene | 2023-03-07 |
| This Study Consists of Two Study Parts Conducted Under a Single IRB. Part I: Short Term ApoE-dependent Cerebral Blood Flow Response to Sirolimus in Cognitively Normal Adults Part II: Short Term ApoE-dependent Cerebral Blood Flow and Lung Perfusion Response to Sirolimus in Cognitively Normal Adults (NCT05386914) | University of Missouri-Columbia | 2023-03-02 |
| Pharmacokinetics of VVN461 Ophthalmic Solution (NCT06906198) | VivaVision Biotech, Inc | 2023-03-01 |
| Overlapping Pain Trajectory Study (NCT05752396) | Children's Hospital Medical Center, Cincinnati | 2023-03-01 |
| Systemic Pharmacokinetic Study of T4032 (Unpreserved Bimatoprost 0.01%) Eye Gel Versus Lumigan® 0.01% Eye Drops in 40 Healthy Volunteers (NCT05729594) | Laboratoires Thea | 2023-02-27 |
| A Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single and Multiple Ascending Doses of ARGX-119 in Healthy Participants (NCT05670704) | argenx | 2023-02-21 |
| A Study To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2086 in Healthy Adult and Elderly Participants (NCT05745207) | Eisai Inc. | 2023-02-20 |
| A Phase Ia Safety and Tolerability Study of BL-001 (NCT05818306) | Bloom Science | 2023-02-20 |
| A Study to Evaluate the Drug-drug Interactions (DDIs) of GP681 With Rosuvastatin, Digoxin, Itraconazole, Oseltamivir in Chinese Healthy Volunteers (NCT05789342) | Jiangxi Qingfeng Pharmaceutical Co. Ltd. | 2023-02-15 |
| Effect of Proprioceptive Knee Braces on the Performance and Endurance of Recreational Soccer Players Aged 60-80 Years (NCT05716165) | Thuasne | 2023-02-14 |
| Bioequivalence Study of Sitagliptin/Metformin Extended-Release Tablets in Healthy Subjects (NCT07679711) | The Affiliated Hospital of Qingdao University | 2023-02-14 |
| Assessment of Navigation Abilities in Children With Cerebral Palsy and Their Peers (NCT06320106) | IRCCS Eugenio Medea | 2023-02-07 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of E2025 in Healthy Participants (NCT05726851) | Eisai Inc. | 2023-02-06 |
| A Study to Determine the Effect Food Has on TAK-721 (Budesonide Oral Suspension) in the Body of Healthy Adults (NCT06268301) | Takeda | 2023-02-06 |
| A Study to Evaluate the Safety, PK of GC2129A in Healthy Volunteers Under Fed Conditions (NCT05729386) | GC Biopharma Corp | 2023-02-06 |
| Effects of Rifaximin on Gut Microbiota and Emotion (NCT05587036) | Universitaire Ziekenhuizen KU Leuven | 2023-02-02 |
| Study of CMAB807X Pre- and Post-change in Manufacturing Site and Xgeva® in Healthy Volunteers (NCT05808673) | Taizhou Mabtech Pharmaceutical Co.,Ltd | 2023-02-01 |
| Clinical Study on Lot-to-lot Consistency and Immune Persistence of Three Commercial Batches of PPSV23 (NCT06314867) | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 2023-01-30 |
| iCP-NI - Safety, Tolerability, Pharmacokinetic, and Immunogenicity Study in Healthy Male and Female Subjects (NCT05740280) | Cellivery Therapeutics, Inc. | 2023-01-19 |
| Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ITI 333 in Healthy Volunteers (NCT05732194) | Intra-Cellular Therapies, Inc. | 2023-01-18 |
| A Study to Evaluate the Safety, PK of GC2129A in Healthy Volunteers Under Fasting Conditions (NCT05703984) | GC Biopharma Corp | 2023-01-17 |
| A Study to Assess the Adverse Events and How Oral ABBV-552 Capsules Moves Through the Body of Healthy Adult Japanese and Han Chinese Participants (NCT05686980) | AbbVie | 2023-01-17 |
| A First-In-Human SAD and MAD Study to Evaluate the Safety, Tolerability, PK and PD of SC Administered ALTB-268 in Healthy Volunteers (NCT05723692) | AltruBio Inc. | 2023-01-17 |
| A Study to Evaluate the Absorption, Metabolism, and Excretion (ADME) of BMS-986435 (NCT05686096) | Bristol-Myers Squibb | 2023-01-16 |
| Multiple Ascending Dose Study of TMP-301 in Healthy Subjects (NCT06025396) | Tempero Bio, Inc. | 2023-01-06 |
| Validation of the Consecutive-Letter Substitution Task (CST) (NCT06066281) | IRCCS San Raffaele | 2023-01-03 |
| Drug-Drug Interaction Study of Itraconazole, Rifampicin and Midazolam With SIM0417/Ritonavir in Healthy Participants (NCT05665647) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2022-12-29 |
| A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (NCT05648214) | Regeneron Pharmaceuticals | 2022-12-27 |
| Safety and Pharmacokinetics of GH002 in Healthy Volunteers (NCT05753956) | GH Research Ireland Limited | 2022-12-22 |
| A Study Evaluating Safety, Tolerability, and Pharmacokinetics of QRL-101 in Healthy Participants (NCT05667779) | QurAlis Corporation | 2022-12-22 |
| Effects of CSL324 in the Lung After Segmental Challenge (NCT05653713) | CSL Behring | 2022-12-20 |
| Oral Vitamin D2 for Prevention of COVID-19 (NCT05673980) | Peking University Third Hospital | 2022-12-18 |
| Aom0319 SAD Study in Healthy Subjects (NCT05555758) | Amckaus PTY LTD. | 2022-12-15 |
| A Study to Evaluate Safety and Pharmacokinetics of ZB002 in Healthy Participants and Participants With Rheumatoid Arthritis (NCT05638854) | Zenas BioPharma (USA), LLC | 2022-12-08 |
| Comparative Bioavailability Study of TAH3311 5 mg Oral Dissolving Film vs ELIQUIS® 5 mg Tablet in Healthy Volunteers (NCT05995119) | TAHO Pharmaceuticals Ltd. | 2022-12-05 |
| Digital Technology Use, Digit Ratio, and Handgrip Strength in University Students (NCT07694960) | Inonu University | 2022-12-01 |
| A Study of the Safety,Tolerability,and Pharmacokinetics of Multiple-Ascending Dose JS1-1-01 in Healty Subjects. (NCT05656274) | Tasly Pharmaceutical Group Co., Ltd | 2022-11-29 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB03-154 in Healthy Participants in Australia (NCT05502549) | Shanghai Zhimeng Biopharma, Inc. | 2022-11-29 |
| First Human Dose Trial for a New Medication to Potentially Treat Liver Diseases (NCT05599945) | Novo Nordisk A/S | 2022-11-23 |
| Open-label Study of the Absorption, Metabolism, and Excretion of [14C]TVB-2640 Following a Single Oral Dose in Healthy Male Subjects (NCT05657834) | Sagimet Biosciences Inc. | 2022-11-21 |
| A Study to Look at Safety and Tolerability of NNC0582-0001, How it is Transported Throughout the Body and How it Works in Healthy Adults (NCT05624580) | Novo Nordisk A/S | 2022-11-15 |
| A Study of Soticlestat in Healthy Adult Nondependent Recreational Drug Users With Central Nervous System (CNS) Depressant Experience (NCT05602818) | Takeda | 2022-11-15 |
| Investigation of Benegut® on Immediate GI Discomfort Relief Caused by Acute Overfeeding in Healthy Subjects (NCT05603416) | Vital Solutions GmbH | 2022-11-09 |
| Zoliflodacin Bioequivalence and Drug-Drug Interaction Study (NCT05635305) | Global Antibiotics Research and Development Partnership | 2022-11-09 |
| A Research Study Looking at the Safety of Multiple Doses of ZP8396 and How it Works in the Body of Healthy Participants (NCT05613387) | Zealand Pharma | 2022-11-07 |
| Study on Performance and Safety of Sentinox in the Prevention of Acute Respiratory Infections (ARI) (NCT05499780) | APR Applied Pharma Research s.a. | 2022-11-07 |
| NVP-1805 Compared to Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Adult Volunteers (BE) (NCT05354713) | NVP Healthcare | 2022-11-05 |
| A Study to Compare Bioavailability of AZD5055 Film-coated Tablet With AZD5055 Oral Suspension and to Assess the Effect of Food and an Acid Reducing Agent on Pharmacokinetics (PK) of AZD5055 in Healthy Subjects. (NCT05630677) | AstraZeneca | 2022-11-04 |
| Study on Two Adjuvanted Dose Levels of Panblok H7+MF59 Compared for Immunogenicity and Safety With an Unadjuvanted Dose of Panblok H7 in Participants 18 Years of Age and Older (NCT05608005) | Sanofi Pasteur, a Sanofi Company | 2022-11-03 |
| Effect of High-Definition Transcranial Direct Current Stimulation (HD-tDCS) on Attentional Control: an fMRI Study on Healthy Participants (NCT05613790) | University of Tehran | 2022-11-02 |
| Effect of CYP2C9*3 Polymorphism on Ibuprofen in Pakistani Population (NCT05983042) | Riphah International University | 2022-11-01 |
| Airway Occlusion Measured During Non-invasive Ventilation to Assess Respiratory Effort (NCT05576246) | Clinica Olivos SMG | 2022-10-30 |
| ELE-101 Safety & Tolerability Study in Healthy Participants and Patients With Depression (NCT05434156) | Eleusis Therapeutics | 2022-10-27 |
| A Trial to Compare the Amount of Centanafadine That Enters the Bloodstream for Two Different Formulations of Centanafadine (NCT07465731) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2022-10-27 |
| Meat And Dietary Pattern Study (NCT05589389) | USDA Beltsville Human Nutrition Research Center | 2022-10-26 |
| Photoplethysmographic Measurements of Pulse Wave Velocity (PWV) and Blood Pressure (BP) (NCT05393401) | University Hospital, Grenoble | 2022-10-25 |
| Feasibility Study of an Innovative Medical Device for Sampling the Contents of the Small Intestine. (NCT05477069) | University Hospital, Grenoble | 2022-10-24 |
| Efficacy and Safety of Pulmonary Function Analysis With Dynamic Digital Radiography Total Respiratory Cycle Photography (NCT05565027) | Shenzhen People's Hospital | 2022-10-20 |
| Pharmacokinetics of Irbesartan High/Amlodipine FDC and Co-administration of Irbesartan High and Amlodipine in Healthy Volunteers (NCT05688085) | Handok Inc. | 2022-10-18 |
| Clinical Investigation to Evaluate the Tolerance of T10070 on Healthy Volunteers (NCT05622435) | Laboratoires Thea | 2022-10-17 |
| A Study to Determine the Absolute Bioavailability and the Absorption, Metabolism, and Elimination Properties of Carbon-14 (14C)E7386 in Healthy Male Participants (NCT05607537) | Eisai Limited | 2022-10-17 |